Annual report pursuant to Section 13 and 15(d)

STOCK-BASED COMPENSATION (Tables)

v3.23.1
STOCK-BASED COMPENSATION (Tables)
12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
SCHEDULE OF AGGREGATE RESTRICTED STOCK AWARDS AND RESTRICTED STOCK UNIT ACTIVITY

The following table summarizes our restricted stock awards activity:

 

    Number of Units     Weighted Average Grant-Date Fair Value  
Outstanding as of December 31, 2020     -       -  
Granted     1,506,000       4.13  
Vested     (633,889 )     3.94  
Forfeited     (4,611 )     3.81  
Outstanding as of December 31, 2021     867,500       4.20  
Granted     136,000       2.72  
Vested     (543,500 )     3.78  
Forfeited     -       -  
Outstanding as of December 31, 2022     460,000       4.32  
SCHEDULE OF STOCK BASED COMPENSATION

A summary of the status of the Company’s outstanding stock options and changes during the years ended December 31, 2022 and 2021, is as follows:

  

    Number of Options     Weighted Average Exercise Price     Weighted Average Grant Date Fair Value     Weighted Average Remaining Contractual Life (Years)  
Balance at January 1, 2021     599,092     $ 2.35     $ -       9.91  
Granted     1,650,000     $ 5.24     $ 3.23       5.31  
Exercised     (19,200 )   $ 1.00     $ -       -  
Cancelled     (50,000 )   $ 1.25     $ -       -  
Expired     -     $ -     $ -       -  
Balance outstanding at December 31, 2021     2,179,892     $ 4.54     $ 2.44       5.93  
                                 
Options exercisable at December 31, 2021     929,892     $ 3.53     $ 1.37       7.36  
                                 
Balance at January 1, 2022     2,179,892     $ 4.54     $ 2.44       5.93  
Granted     190,000     $ 1.92     $ 1.43       6.85  
Exercised     -     $ -     $ -       -  
Cancelled     (250,000 )   $ 5.35     $ -       -  
Expired     (191 )   $ -     $ -       -  
Balance outstanding at December 31, 2022     2,119,701     $ 4.16     $ 2.25       5.23  
                                 
Options exercisable at December 31, 2022     1,259,701     $ 3.51     $ 1.68       6.25